| 2022, July 15 | 2020, November 20
| Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
| NIH/NIDDK |
| 2022, August 1 | 2022, August 31 | INCENTIVE GRANTS
| APhA |
| 2021, August 9 | 2022, September 15 [LOI/Pre-App] | About the American Lung Association COVID-19 and Emerging
Respiratory Viruses Research Award | ALA |
| 2022, January 31 | 2022, August 25 | Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional) | NIMH/NIH/DHHS |
| 2022, April 25 | 2022, August 26 [LOI/Pre-App] | The RADx-UP CDCC Rapid Research Pilot Program | RADx-UP Coordination and Data Collection Center (CDCC) |
| 2022, April 25 | 2022, August 26 [LOI/Pre-App] | RADx-Up Community Collaboration Mini-Grant Program | RADx-UP Coordination and Data Collection Center (CDCC) |
| 2022, July 7 | 2022, August 31 | Addressing the Impact of COVID-19 on Student Learning in North Carolina | The North Carolina Collaboratory |
| 2020, September 20 (Updated March 20, 2022) | 2022, November 17 | Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) | NIMH/NIAAA/NIH |
| 2022, May 23 | 2022, October 1 | D&I Pilot Awards | ASPiRE Center |
| 2021, December 21 | 2022, October 5 | Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional) | NIH/DHHS |
| 2022, April 4 | 2022, October 13 [Optional] [LOI/Pre-App
May 31, 2022 | Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional) | NIMH/NIH/DHHS |
| 2022, January 8 (Updated March 20, 2022) | 2022, October 16 | NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) | NIBIB |
| 2020, February 3 | 2023, February 3 | FCO--AMENDMENT --- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement | Department of Health & Human Services |
| 2022, December 2 | 2023, January 26 | Notice of Special Interest (NOSI): Administrative Supplements for Research on Sex and/or Gender Influences (Admin Supp Clinical Trial Optional) | NIH/DHHS |
| 2020, December 23 | 2023, June 1 | Notice of Special Interest (NOSI): Administrative Supplements for COVID-19 Impacted NIMH Research | National Institute of Mental Health/NIH/DHHS |
| 2021, February 3 | 2024, August 16 | Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | National Center for Advancing Translational Sciences/NIH/DHHS |
| 2021, February 26 | 2024, August 16 | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | National Center for Advancing Translational Sciences/NIH/DHHS |
| Continuous Submission | Duke Energy Grants | Duke Energy |
| Continuous Submission | Innovation Fund | Comcast |
| 2018, October 3 | Continuous Submission | Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) | National Institutes of Health/DHHS |
| 2020, April 2 | Continuous Submission | Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (Defunct) | National Institutes of Health/DHHS |
| 2020, March 10 | Continuous Submission | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | National Institutes of Health/DHHS |
| 2020, October 9 | Continuous Submission | Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | National Institutes of Health/DHHS |
| 2021, July 11 | Continuous Submission | Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) | National Institute of Allergy and Infectious Diseases/NIH/DHHS |
| Variable | Medical Education Grants: Outpatient Management of COVID-19 | Pfizer Pharmaceuticals |
| Variable | Competitive Grant Program: Management of Non-Communicable Diseases (NCD) for Health Care Providers | Pfizer Pharmaceuticals |
| Variable | Coalition for Epidemic Preparedness Innovations (CEPI) | CEPI |
